02/26/21 Akorn Announces Review of Strategic Alternatives for the Akorn Consumer Health Business
02/11/21 Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%
10/28/20 Akorn Announces Its New Board of Directors
10/01/20 Akorn Successfully Completes Sale to Lenders and Exits Chapter 11 Protection
06/22/20 Akorn Animal Health Announces Launch of Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment

Events Events

Date Title Download
No upcoming events scheduled. Please check back.

Annual Reports Media Contact

Please direct all media inquiries to